Search research articles
Contact Us
Filters
Showing results (381-390 of 565) with videos related to
Page
of 57
Sort By:
The Journal of Urology
|
January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Andrology
|
February 16, 2013
Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction
M Kimura, L L Bañez, T J Polascik, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
World Journal of Surgery
|
June 1, 2006
An analysis of risk factors associated with failure of below knee amputations
Vincent S K Yip, Nee Beng Teo, Robert Johnstone, et al.
The Journal of Urology
|
January 20, 2010
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk
Ping Tang, Leon Sun, Matthew A Uhlman, et al.
Journal of Viral Hepatitis
|
June 29, 2020
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials
Gayatri Nangia, John M Vierling, Paul Kwo, et al.
Cancer Research
|
February 24, 2001
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer
T R DeGrado, R E Coleman, S Wang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2022
Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients
Bradley J Gardiner, Sue J Lee, Allisa N Robertson, et al.
Organic & Biomolecular Chemistry
|
April 8, 2011
Anhydrous TEMPO-H: reactions of a good hydrogen atom donor with low-valent carbon centres
Nick A Giffin, Miller Makramalla, Arthur D Hendsbee, et al.
The Journal of Infectious Diseases
|
October 1, 1996
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160
B Fleury, G Janvier, G Pialoux, et al.
Page
of 57
Search research articles
Search
Showing results (381-390 of 565) with videos related to
Sort By:
Page
of 57
The Journal of Urology
|
January 22, 2010
Tumor percent involvement predicts prostate specific antigen recurrence after radical prostatectomy only in men with smaller prostate
Matthew A Uhlman, Leon Sun, Danielle A Stackhouse, et al.
Andrology
|
February 16, 2013
Sexual bother and function after radical prostatectomy: predictors of sexual bother recovery in men despite persistent post-operative sexual dysfunction
M Kimura, L L Bañez, T J Polascik, et al.
Anti-Cancer Drugs
|
April 1, 1995
Fused pyrazine mono-N-oxides as bioreductive drugs. III. Characterization of RB 90740 in vitro and in vivo
M A Naylor, G E Adams, A Haigh, et al.
World Journal of Surgery
|
June 1, 2006
An analysis of risk factors associated with failure of below knee amputations
Vincent S K Yip, Nee Beng Teo, Robert Johnstone, et al.
The Journal of Urology
|
January 20, 2010
Initial prostate specific antigen 1.5 ng/ml or greater in men 50 years old or younger predicts higher prostate cancer risk
Ping Tang, Leon Sun, Matthew A Uhlman, et al.
Journal of Viral Hepatitis
|
June 29, 2020
Safety and tolerability of elbasvir/grazoprevir in chronic hepatitis C virus therapy: Integrated analysis from clinical trials
Gayatri Nangia, John M Vierling, Paul Kwo, et al.
Cancer Research
|
February 24, 2001
Synthesis and evaluation of 18F-labeled choline as an oncologic tracer for positron emission tomography: initial findings in prostate cancer
T R DeGrado, R E Coleman, S Wang, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
|
July 22, 2022
Real-world experience of Quantiferon-CMV directed prophylaxis in lung transplant recipients
Bradley J Gardiner, Sue J Lee, Allisa N Robertson, et al.
Organic & Biomolecular Chemistry
|
April 8, 2011
Anhydrous TEMPO-H: reactions of a good hydrogen atom donor with low-valent carbon centres
Nick A Giffin, Miller Makramalla, Arthur D Hendsbee, et al.
The Journal of Infectious Diseases
|
October 1, 1996
Memory cytotoxic T lymphocyte responses in human immunodeficiency virus type 1 (HIV-1)-negative volunteers immunized with a recombinant canarypox expressing gp 160 of HIV-1 and boosted with a recombinant gp160
B Fleury, G Janvier, G Pialoux, et al.
Page
of 57